Marianna Chinucci
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-world semaglutide in obesity cohort: effectiveness, safety and persistence across sex, BMI, and prior GLP-1RA treatment.
Journal: Frontiers in endocrinology
Published: February 27, 2026
Fetuin-A: a potential molecular link between obesity, diabetes (type 2 and type 1) and metabolic steatotic liver disease (MASLD).
Journal: Journal of endocrinological investigation
Published: January 07, 2026
Impact of metabolic comorbidities on the clinical course of West Nile virus infection.
Journal: Journal of endocrinological investigation
Published: December 06, 2025
Sex Differences in MASLD After Age 50: Presentation, Diagnosis, and Clinical Implications.
Journal: Biomedicines
Published: August 11, 2025
The Challenge of Type 3c Diabetes: From Accurate Diagnosis to Effective Treatment.
Journal: JCEM case reports
Published: March 26, 2025
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.
Journal: Biomedicines
Published: March 08, 2025
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target.
Journal: International journal of molecular sciences
Published: September 04, 2024
Sex-Differences in Response to Treatment with Liraglutide 3.0 mg.
Journal: Journal of clinical medicine
Published: May 07, 2024
The intricate relationship between obesity, type 2 diabetes and female breast cancer: A retrospective study of 335 women.
Journal: Obesity science & practice
Published: February 29, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026